RYAAY

63.75

+2.71%↑

KNEBV.FI

53.94

+1.43%↑

MTX1

377.8

+0.99%↑

WRT1V.FI

24.3

+0.29%↑

BVI

26.76

+1.13%↑

RYAAY

63.75

+2.71%↑

KNEBV.FI

53.94

+1.43%↑

MTX1

377.8

+0.99%↑

WRT1V.FI

24.3

+0.29%↑

BVI

26.76

+1.13%↑

RYAAY

63.75

+2.71%↑

KNEBV.FI

53.94

+1.43%↑

MTX1

377.8

+0.99%↑

WRT1V.FI

24.3

+0.29%↑

BVI

26.76

+1.13%↑

RYAAY

63.75

+2.71%↑

KNEBV.FI

53.94

+1.43%↑

MTX1

377.8

+0.99%↑

WRT1V.FI

24.3

+0.29%↑

BVI

26.76

+1.13%↑

RYAAY

63.75

+2.71%↑

KNEBV.FI

53.94

+1.43%↑

MTX1

377.8

+0.99%↑

WRT1V.FI

24.3

+0.29%↑

BVI

26.76

+1.13%↑

Search

Zumtobel Group AG

Open

4.465 1.13

Overview

Share price change

24h

Current

Min

4.38

Max

4.465

Key metrics

By Trading Economics

Income

7.6M

2.3M

Sales

19M

269M

P/E

Sector Avg

13.236

42.612

EPS

0.132

Dividend yield

3.13

Profit margin

0.856

EBITDA

34M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+54.06% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.13%

2.27%

Next Earnings

4 Sept 2025

Market Stats

By TradingEconomics

Market Cap

-5.3M

207M

Previous open

3.34

Previous close

4.465

Zumtobel Group AG Chart

Past performance is not a reliable indicator of future results.

Related News

4 Aug 2025, 21:42 UTC

Earnings
Acquisitions, Mergers, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 Aug 2025, 21:21 UTC

Earnings
Major Market Movers

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 Aug 2025, 20:45 UTC

Earnings

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 Aug 2025, 19:15 UTC

Major Market Movers

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 Aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 Aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4 Aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4 Aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 Aug 2025, 21:30 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 21:21 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 Aug 2025, 21:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 Aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss $938M >RIG

4 Aug 2025, 20:25 UTC

Earnings

Transocean 2Q Loss/Shr $1.06 >RIG

4 Aug 2025, 20:18 UTC

Earnings

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 Aug 2025, 20:15 UTC

Earnings

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 Aug 2025, 20:14 UTC

Earnings

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 Aug 2025, 20:13 UTC

Earnings

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 Aug 2025, 20:09 UTC

Earnings

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 Aug 2025, 20:06 UTC

Earnings

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 Aug 2025, 20:01 UTC

Earnings

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 Aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 Aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 Aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 Aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Peer Comparison

Price change

Zumtobel Group AG Forecast

Price Target

By TipRanks

54.06% upside

12 Months Forecast

Average 11 EUR  54.06%

High 11 EUR

Low 11 EUR

Based on 1 Wall Street analysts offering 12 month price targets forZumtobel Group AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zumtobel Group AG

Zumtobel Group AG, formerly known as Zumtobel AG, is an Austria-based company engaged in the provision of lighting solutions, luminaries, light management systems and lighting components for interior and exterior applications. The Company operates in two segments: The Lighting Segment covers luminaries, lighting management and lighting solutions business for indoor and outdoor applications, and comprises the brands Zumtobel, Thorn and acdc, as well as original equipment manufacturer (OEM) brand Reiss. The Components Segment is focused primarily on the development and marketing of control gear for conventional lighting components, light-emitting diodes (LED) converters and LED/organic light-emitting diode (OLED) modules, lighting management systems and connection technology under the Tridonic and acdc brands. The Company operates AC/DC LED Holdings Ltd as a majority owned subsidiary.